Acurx Pharmaceuticals, Inc. (ACXP) stock
ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.99+0.05 (+5.88%)
Close on Nov 17, 2026Market cap $5.22MP/E –Yield –
Acurx Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Acurx Pharmaceuticals
Acurx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?